rs745807085
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000057.4(BLM):c.298_299delCA(p.Gln100GlufsTer42) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q100Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000057.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bloom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Orphanet, Genomics England PanelApp, ClinGen
- osteosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000057.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | NM_000057.4 | MANE Select | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 22 | NP_000048.1 | ||
| BLM | NM_001287246.2 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 4 of 23 | NP_001274175.1 | |||
| BLM | NM_001287247.2 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 20 | NP_001274176.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BLM | ENST00000355112.8 | TSL:1 MANE Select | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 22 | ENSP00000347232.3 | ||
| BLM | ENST00000560509.5 | TSL:1 | c.298_299delCA | p.Gln100GlufsTer42 | frameshift | Exon 3 of 20 | ENSP00000454158.1 | ||
| BLM | ENST00000559724.5 | TSL:1 | n.298_299delCA | non_coding_transcript_exon | Exon 3 of 22 | ENSP00000453359.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251314 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461856Hom.: 0 AF XY: 0.00000688 AC XY: 5AN XY: 727226 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Bloom syndrome Pathogenic:4
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change creates a premature translational stop signal (p.Gln100Glufs*42) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). This variant is present in population databases (rs745807085, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with pancreatic ductal adenocarcinoma (PMID: 26546047). ClinVar contains an entry for this variant (Variation ID: 371569). For these reasons, this variant has been classified as Pathogenic.
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.298_299delCA pathogenic mutation, located in coding exon 2 of the BLM gene, results from a deletion of two nucleotides at nucleotide positions 298 to 299, causing a translational frameshift with a predicted alternate stop codon (p.Q100Efs*42). This alteration was detected by whole exome sequencing in a pancreatic cancer patient and segregated in 2 out of 3 pancreatic cancer affected family members and/or obligate carriers; a predicted pathogenic alteration was also detected in the SPP1 gene in the proband (Smith AL et al. Cancer Lett. 2016 Jan 28;370(2):302-12). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
not provided Pathogenic:1
Identified in a patient with personal and family history of pancreatic cancer (Smith et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 29625052, 26546047)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at